MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
| |||||||||||||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP NET SALES TO NON-GAAP NET SALES | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 |
| |||||||
Net sales, as reported |
$ |
557,647 |
|
|
$ |
543,207 |
|
|
$ |
2,173,334 |
|
|
$ |
2,147,036 |
|
Distributor revenue recognition adjustment |
10,791 |
|
|
3,983 |
|
|
40,501 |
|
|
13,570 |
| ||||
Non-GAAP net sales |
$ |
568,438 |
|
|
$ |
547,190 |
|
|
$ |
2,213,835 |
|
|
$ |
2,160,606 |
|
| |||||||||||||||
RECONCILIATION OF GAAP GROSS PROFIT TO NON-GAAP GROSS PROFIT | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 |
| |||||||
Gross profit, as reported |
$ |
302,779 |
|
|
$ |
313,632 |
|
|
$ |
1,205,464 |
|
|
$ |
1,229,564 |
|
Distributor revenue recognition adjustment, net of product cost |
5,395 |
|
|
1,792 |
|
|
23,794 |
|
|
6,357 |
| ||||
Share-based compensation expense |
1,927 |
|
|
2,025 |
|
|
8,252 |
|
|
9,010 |
| ||||
Manufacturing excursion |
3,624 |
|
|
— |
|
|
3,624 |
|
|
— |
| ||||
Acquisition-related restructuring and acquired inventory valuation costs |
18,197 |
|
|
1,511 |
|
|
45,646 |
|
|
26,203 |
| ||||
Non-GAAP gross profit |
$ |
331,922 |
|
|
$ |
318,960 |
|
|
$ |
1,286,780 |
|
|
$ |
1,271,134 |
|
Non-GAAP gross profit percentage |
58.4 |
% |
|
58.3 |
% |
|
58.1 |
% |
|
58.8 |
% | ||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 | ||||||||
Research and development expenses, as reported |
$ |
95,638 |
|
|
$ |
87,662 |
|
|
$ |
372,596 |
|
|
$ |
349,543 |
|
Share-based compensation expense |
(8,399) |
|
|
(7,519) |
|
|
(32,022) |
|
|
(28,164) |
| ||||
Non-GAAP research and development expenses |
$ |
87,239 |
|
|
$ |
80,143 |
|
|
$ |
340,574 |
|
|
$ |
321,379 |
|
Non-GAAP research and development expenses as a percentage of net sales |
15.3 |
% |
|
14.6 |
% |
|
15.4 |
% |
|
14.9 |
% | ||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES TO NON-GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 | ||||||||
Selling, general and administrative expenses, as reported |
$ |
78,293 |
|
|
$ |
67,778 |
|
|
$ |
301,670 |
|
|
$ |
274,815 |
|
Share-based compensation expense |
(6,991) |
|
|
(5,639) |
|
|
(31,146) |
|
|
(21,422) |
| ||||
Acquisition-related costs |
(5,040) |
|
|
(741) |
|
|
(9,738) |
|
|
(4,001) |
| ||||
Non-GAAP selling, general and administrative expenses |
$ |
66,262 |
|
|
$ |
61,398 |
|
|
$ |
260,786 |
|
|
$ |
249,392 |
|
Non-GAAP selling, general and administrative expenses as a percentage of net sales |
11.7 |
% |
|
11.2 |
% |
|
11.8 |
% |
|
11.5 |
% | ||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP OPERATING EXPENSES TO NON-GAAP OPERATING EXPENSES | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 | ||||||||
Operating expenses, as reported |
$ |
222,833 |
|
|
$ |
203,285 |
|
|
$ |
853,119 |
|
|
$ |
803,944 |
|
Share-based compensation expense |
(15,390) |
|
|
(13,158) |
|
|
(63,168) |
|
|
(49,586) |
| ||||
Acquisition-related costs |
(5,040) |
|
|
(741) |
|
|
(9,738) |
|
|
(4,001) |
| ||||
Amortization of acquired intangible assets |
(48,132) |
|
|
(47,087) |
|
|
(174,896) |
|
|
(176,746) |
| ||||
Special charges, net |
(770) |
|
|
(758) |
|
|
(3,957) |
|
|
(2,840) |
| ||||
Non-GAAP operating expenses |
$ |
153,501 |
|
|
$ |
141,541 |
|
|
$ |
601,360 |
|
|
$ |
570,771 |
|
Non-GAAP operating expenses as a percentage of net sales |
27.0 |
% |
|
25.9 |
% |
|
27.2 |
% |
|
26.4 |
% | ||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP OPERATING INCOME TO NON-GAAP OPERATING INCOME | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 | ||||||||
Operating income, as reported |
$ |
79,946 |
|
|
$ |
110,347 |
|
|
$ |
352,345 |
|
|
$ |
425,620 |
|
Distributor revenue recognition adjustment |
5,395 |
|
|
1,792 |
|
|
23,794 |
|
|
6,357 |
| ||||
Share-based compensation expense |
17,317 |
|
|
15,183 |
|
|
71,420 |
|
|
58,596 |
| ||||
Manufacturing excursion |
3,624 |
|
|
— |
|
|
3,624 |
|
|
— |
| ||||
Acquisition-related restructuring, acquired inventory valuation and other costs |
23,237 |
|
|
2,252 |
|
|
55,384 |
|
|
30,204 |
| ||||
Amortization of acquired intangible assets |
48,132 |
|
|
47,087 |
|
|
174,896 |
|
|
176,746 |
| ||||
Special charges, net |
770 |
|
|
758 |
|
|
3,957 |
|
|
2,840 |
| ||||
Non-GAAP operating income |
$ |
178,421 |
|
|
$ |
177,419 |
|
|
$ |
685,420 |
|
|
$ |
700,363 |
|
Non-GAAP operating income as a percentage of net sales |
31.4 |
% |
|
32.4 |
% |
|
31.0 |
% |
|
32.4 |
% | ||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP OTHER EXPENSE, NET TO NON-GAAP OTHER EXPENSE, NET | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 | ||||||||
Other expense, net, as reported |
$ |
(22,277) |
|
|
$ |
(48,138) |
|
|
$ |
(70,707) |
|
|
$ |
(79,396) |
|
Loss on retirement of convertible debentures |
— |
|
|
50,631 |
|
|
— |
|
|
50,631 |
| ||||
Gain on equity securities and equity method investment |
— |
|
|
(18,469) |
|
|
(16,147) |
|
|
(18,469) |
| ||||
Non-cash other expense, net |
15,920 |
|
|
6,854 |
|
|
53,005 |
|
|
14,165 |
| ||||
Impairment on available-for-sale investment |
— |
|
|
— |
|
|
3,995 |
|
|
— |
| ||||
Other expenses on acquisition restructuring |
— |
|
|
— |
|
|
501 |
|
|
— |
| ||||
Non-GAAP other expense, net |
$ |
(6,357) |
|
|
$ |
(9,122) |
|
|
$ |
(29,353) |
|
|
$ |
(33,069) |
|
Non-GAAP other expense, net, as a percentage of net sales |
(1.1) |
% |
|
(1.7) |
% |
|
(1.3) |
% |
|
(1.5) |
% | ||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP INCOME TAX BENEFIT TO NON-GAAP INCOME TAX PROVISION | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 | ||||||||
Income tax benefit, as reported |
$ |
(9,742) |
|
|
$ |
(36,559) |
|
|
$ |
(42,632) |
|
|
$ |
(19,418) |
|
Income tax rate, as reported |
(16.9)% |
|
|
(58.9)% |
|
|
(15.2)% |
|
|
(5.6)% |
| ||||
Distributor revenue recognition adjustment |
1,911 |
|
|
251 |
|
|
8,721 |
|
|
1,074 |
| ||||
Share-based compensation expense |
5,446 |
|
|
3,755 |
|
|
23,012 |
|
|
10,640 |
| ||||
Manufacturing excursion |
1,324 |
|
|
— |
|
|
1,324 |
|
|
— |
| ||||
Acquisition-related restructuring, acquired inventory valuation costs, intangible asset amortization and other costs |
2,018 |
|
|
3,365 |
|
|
34,799 |
|
|
18,061 |
| ||||
Special charges, net |
31 |
|
|
239 |
|
|
1,445 |
|
|
962 |
| ||||
Loss on retirement of convertible debentures |
— |
|
|
18,809 |
|
|
— |
|
|
18,809 |
| ||||
Non-cash other expense, net |
5,692 |
|
|
2,546 |
|
|
19,426 |
|
|
5,262 |
| ||||
Gain on equity securities and equity method investment |
— |
|
|
— |
|
|
(31) |
|
|
— |
| ||||
Impairment on available-for-sale investment |
— |
|
|
— |
|
|
1,472 |
|
|
— |
| ||||
Non-recurring tax events |
12,300 |
|
|
26,735 |
|
|
24,706 |
|
|
36,718 |
| ||||
Non-GAAP income tax provision |
$ |
18,980 |
|
|
$ |
19,141 |
|
|
$ |
72,242 |
|
|
$ |
72,108 |
|
Non-GAAP income tax rate |
11.0 |
% |
|
11.4 |
% |
|
11.0 |
% |
|
10.8 |
% | ||||
|
|
|
| ||||||||||||
RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO MICROCHIP TECHNOLOGY AND GAAP DILUTED NET INCOME PER COMMON SHARE ATTRIBUTABLE TO MICROCHIP TECHNOLOGY STOCKHOLDERS TO NON-GAAP NET INCOME ATTRIBUTABLE TO MICROCHIP TECHNOLOGY AND NON-GAAP DILUTED NET INCOME PER COMMON SHARE ATTRIBUTABLE TO MICROCHIP TECHNOLOGY STOCKHOLDERS | |||||||||||||||
|
Three months ended |
|
Twelve months ended | ||||||||||||
|
March 31, |
|
March 31, | ||||||||||||
|
2016 |
|
2015 |
|
2016 |
|
2015 | ||||||||
Net income attributable to Microchip Technology, as reported |
$ |
67,355 |
|
|
$ |
99,402 |
|
|
$ |
324,132 |
|
|
$ |
369,009 |
|
Noncontrolling interests |
— |
|
|
(995) |
|
|
(375) |
|
|
(4,618) |
| ||||
Distributor revenue recognition adjustment, net of tax effect |
3,484 |
|
|
1,541 |
|
|
15,073 |
|
|
5,283 |
| ||||
Share-based compensation expense, net of tax effect |
11,871 |
|
|
11,428 |
|
|
48,408 |
|
|
47,956 |
| ||||
Manufacturing excursion, net of tax effect |
2,300 |
|
|
— |
|
|
2,300 |
|
|
— |
| ||||
Acquisition-related restructuring, acquired inventory valuation costs, intangible asset amortization and other costs, net of tax effect |
69,351 |
|
|
45,974 |
|
|
195,982 |
|
|
188,889 |
| ||||
Special charges, net of tax effect |
739 |
|
|
519 |
|
|
2,512 |
|
|
1,878 |
| ||||
Loss on retirement of convertible debentures, net of tax effect |
— |
|
|
31,822 |
|
|
— |
|
|
31,822 |
| ||||
Non-cash other expense, net of tax effect |
10,228 |
|
|
4,308 |
|
|
33,579 |
|
|
8,903 |
| ||||
Gain on equity securities and equity method investment, net of tax effect |
— |
|
|
(18,469) |
|
|
(16,116) |
|
|
(18,469) |
| ||||
Impairment on available-for-sale investment, net of tax effect |
— |
|
|
— |
|
|
2,523 |
|
|
— |
| ||||
Non-recurring tax events |
(12,300) |
|
|
(26,735) |
|
|
(24,706) |
|
|
(36,718) |
| ||||
Non-GAAP net income attributable to Microchip Technology |
$ |
153,028 |
|
|
$ |
148,795 |
|
|
$ |
583,312 |
|
|
$ |
593,935 |
|
Non-GAAP net income attributable to Microchip Technology as a percentage of net sales |
26.9 |
% |
|
27.2 |
% |
|
26.3 |
% |
|
27.5 |
% | ||||
|
|
|
|
|
|
|
| ||||||||
Diluted net income per common share attributable to Microchip Technology stockholders, as reported |
$ |
0.31 |
|
|
$ |
0.45 |
|
|
$ |
1.49 |
|
|
$ |
1.65 |
|
Non-GAAP diluted net income per common share attributable to Microchip Technology stockholders |
$ |
0.70 |
|
|
$ |
0.68 |
|
|
$ |
2.68 |
|
|
$ |
2.66 |
|
Diluted common shares outstanding, as reported |
217,711 |
|
|
220,947 |
|
|
217,388 |
|
|
223,561 |
| ||||
Diluted common shares outstanding Non-GAAP |
217,711 |
|
|
220,420 |
|
|
217,260 |
|
|
223,017 |
|